Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the completion of its $550 million manufacturing plant in the town of Holly Springs ...

Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

Pharmaceutical major Torrent Pharma on Friday announced its earnings for the third quarter of the current fiscal, and ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

根据Silo Pharma的新闻稿,该公司已为创伤后应激障碍 (PTSD)治疗申请了临时专利。该申请专注于慢性靶向特定受体,以潜在延长对某些应激诱导行为的行为效应。Silo Pharma目前的流动比率为7.9,维持着强劲的流动性来资助其开发管线,尽管 InvestingPro 跟踪的分析师预计今年该公司不会盈利,2024年预计每股收益为-$0.90。

伦敦和纽约 - 目前市值3654万美元、股价1.04美元的生物技术公司OKYO Pharma Limited (NASDAQ: OKYO)宣布获得140万美元的非稀释性融资。该公司致力于开发眼科疾病治疗方案。根据 InvestingPro 数据，该公司面临一些财务挑战，短期债务超过流动资产。这笔资金旨在支持公司的研发工作，特别是针对目前尚无FDA批准疗法的神经性角膜疼痛 ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Ascentage Pharma Group said its American depositary shares were slated to begin trading on the Nasdaq Global Market on Friday, with its initial public offering priced at $17.25 per ADS.